Lipocine (LPCN) EBT Margin (2018 - 2025)
Lipocine's EBT Margin came in at -2781.46% for Q3 2025, down 2427.33 percentage points from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) EBT Margin (2018 - 2025) Analysis & Trends
Over the trailing twelve months to Sep 30, 2025, Lipocine reported EBT Margin of -126.66%, down 72.53 percentage points year-over-year; for FY2024, it was 0.08%, up 573.65 percentage points from FY2023.
- EBT Margin carries a five-year change of +7883.68 percentage points (FY2019 to FY2024).
- Going back by year, EBT Margin was -573.57% in FY2023 (+1578.02 pp), -2151.59% in FY2022 (-2147.66 pp) and -3.93% in FY2021.
- The Q3 2025 figure represents the lowest quarterly EBT Margin since Q2 2024.
- Business Quant data shows LPCN's EBT Margin at -354.13% (Q2 2025), -1986.57% (Q1 2025) and 51.04% (Q4 2024) in the three quarters before Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -4.34% |
| 10 | Lipocine | 8.72 Mn | -59.00 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -2,781.46% |
| Jun 30, 2025 | -354.13% |
| Mar 31, 2025 | -1,986.57% |
| Dec 31, 2024 | 51.04% |
| Jun 30, 2024 | -3,425.62% |
| Mar 31, 2024 | 46.13% |
| Sep 30, 2023 | -213.04% |
| Mar 31, 2023 | -7,037.70% |
| Jun 30, 2022 | -526.36% |
| Dec 31, 2021 | 78.48% |
| Sep 30, 2021 | -5,602.36% |
| Sep 30, 2019 | -1,854.78% |
| Mar 31, 2018 | -635.30% |
API Access
Lipocine EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();